Raphael Pharmaceutical Stock Technical Analysis
| RAPH Stock | 1.40 0.00 0.00% |
As of the 9th of February, Raphael Pharmaceutical holds the Variance of 124.28, risk adjusted performance of 0.0768, and Coefficient Of Variation of 1193.17. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Raphael Pharmaceutical, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for eleven technical drivers for Raphael Pharmaceutical, which can be compared to its competitors.
Raphael Pharmaceutical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Raphael, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RaphaelRaphael |
Raphael Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Raphael Pharmaceutical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Raphael Pharmaceutical.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Raphael Pharmaceutical on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Raphael Pharmaceutical or generate 0.0% return on investment in Raphael Pharmaceutical over 90 days. Raphael Pharmaceutical is related to or competes with Voyageur Pharmaceuticals, Avicanna, and Mydecine Innovations. More
Raphael Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Raphael Pharmaceutical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Raphael Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0758 | |||
| Maximum Drawdown | 86.67 |
Raphael Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Raphael Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Raphael Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Raphael Pharmaceutical historical prices to predict the future Raphael Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0768 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.91) |
Raphael Pharmaceutical February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0768 | |||
| Market Risk Adjusted Performance | (0.90) | |||
| Mean Deviation | 2.6 | |||
| Coefficient Of Variation | 1193.17 | |||
| Standard Deviation | 11.15 | |||
| Variance | 124.28 | |||
| Information Ratio | 0.0758 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.91) | |||
| Maximum Drawdown | 86.67 | |||
| Skewness | 7.02 | |||
| Kurtosis | 56.36 |
Raphael Pharmaceutical Backtested Returns
Raphael Pharmaceutical appears to be out of control, given 3 months investment horizon. Raphael Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0851, which implies the firm had a 0.0851 % return per unit of risk over the last 3 months. By analyzing Raphael Pharmaceutical's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please evaluate Raphael Pharmaceutical's Risk Adjusted Performance of 0.0768, coefficient of variation of 1193.17, and Variance of 124.28 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Raphael Pharmaceutical holds a performance score of 6. The company holds a Beta of -1.02, which implies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Raphael Pharmaceutical are expected to decrease slowly. On the other hand, during market turmoil, Raphael Pharmaceutical is expected to outperform it slightly. Please check Raphael Pharmaceutical's treynor ratio and rate of daily change , to make a quick decision on whether Raphael Pharmaceutical's historical price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Raphael Pharmaceutical has no correlation between past and present. Overlapping area represents the amount of predictability between Raphael Pharmaceutical time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Raphael Pharmaceutical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Raphael Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.84 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Raphael Pharmaceutical technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Raphael Pharmaceutical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Raphael Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Raphael Pharmaceutical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Raphael Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Raphael Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Raphael Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Raphael Pharmaceutical. By analyzing Raphael Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Raphael Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Raphael Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
Raphael Pharmaceutical February 9, 2026 Technical Indicators
Most technical analysis of Raphael help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Raphael from various momentum indicators to cycle indicators. When you analyze Raphael charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0768 | |||
| Market Risk Adjusted Performance | (0.90) | |||
| Mean Deviation | 2.6 | |||
| Coefficient Of Variation | 1193.17 | |||
| Standard Deviation | 11.15 | |||
| Variance | 124.28 | |||
| Information Ratio | 0.0758 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.91) | |||
| Maximum Drawdown | 86.67 | |||
| Skewness | 7.02 | |||
| Kurtosis | 56.36 |
Raphael Pharmaceutical February 9, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Raphael stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 1.40 | ||
| Day Typical Price | 1.40 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Raphael OTC Stock analysis
When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |